GlassScriptPhysician profile
Anthony K Nguyen
NPI 1841234333
$5,812.44
in general payments reported to CMS, 2019-2025
40 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what 90% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,150 · 2020: $214 · 2021: $738 · 2022: $780 · 2023: $903 · 2024: $986 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,919 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,918.77 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $729.20 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $688.43 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $666.26 | 2019-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $419.80 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Pfizer INC. | $333.58 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.19 | 2019-2025 | Jardiance, Synjardy |
| Otsuka America Pharmaceutical, INC. | $283.13 | 2023-2025 | Rexulti |
| Amarin Pharma, INC. | $255.44 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $190.34 | 2019-2023 | Camzyos, Eliquis |
| Novo Nordisk INC | $186.29 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $186.27 | 2022-2025 | |
| Edwards Lifesciences Corporation | $169.36 | 2022 | |
| Medtronic, INC. | $138.33 | 2021 | |
| Dexcom, INC. | $98.62 | 2022-2023 | Dexcom G6 Transmitter |
| Depuy Synthes Sales INC. | $97.69 | 2020-2024 | Embotrap |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.